PortfoliosLab logo
IOSP vs. CC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IOSP and CC is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

IOSP vs. CC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innospec Inc. (IOSP) and The Chemours Company (CC). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

IOSP:

-0.98

CC:

-1.02

Sortino Ratio

IOSP:

-1.40

CC:

-1.84

Omega Ratio

IOSP:

0.82

CC:

0.79

Calmar Ratio

IOSP:

-0.87

CC:

-0.77

Martin Ratio

IOSP:

-1.78

CC:

-1.59

Ulcer Index

IOSP:

17.66%

CC:

37.31%

Daily Std Dev

IOSP:

31.66%

CC:

58.21%

Max Drawdown

IOSP:

-91.17%

CC:

-86.15%

Current Drawdown

IOSP:

-31.82%

CC:

-73.70%

Fundamentals

Market Cap

IOSP:

$2.22B

CC:

$1.67B

EPS

IOSP:

$1.08

CC:

$0.18

PE Ratio

IOSP:

82.40

CC:

62.06

PEG Ratio

IOSP:

-2.95

CC:

1.67

PS Ratio

IOSP:

1.24

CC:

0.29

PB Ratio

IOSP:

1.74

CC:

2.89

Total Revenue (TTM)

IOSP:

$1.79B

CC:

$5.80B

Gross Profit (TTM)

IOSP:

$512.30M

CC:

$1.10B

EBITDA (TTM)

IOSP:

$201.50M

CC:

$640.00M

Returns By Period

In the year-to-date period, IOSP achieves a -19.14% return, which is significantly higher than CC's -32.26% return.


IOSP

YTD

-19.14%

1M

3.57%

6M

-24.74%

1Y

-30.82%

5Y*

5.51%

10Y*

8.42%

CC

YTD

-32.26%

1M

-0.88%

6M

-39.40%

1Y

-59.30%

5Y*

1.26%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IOSP vs. CC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IOSP
The Risk-Adjusted Performance Rank of IOSP is 55
Overall Rank
The Sharpe Ratio Rank of IOSP is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of IOSP is 77
Sortino Ratio Rank
The Omega Ratio Rank of IOSP is 77
Omega Ratio Rank
The Calmar Ratio Rank of IOSP is 33
Calmar Ratio Rank
The Martin Ratio Rank of IOSP is 22
Martin Ratio Rank

CC
The Risk-Adjusted Performance Rank of CC is 44
Overall Rank
The Sharpe Ratio Rank of CC is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of CC is 33
Sortino Ratio Rank
The Omega Ratio Rank of CC is 55
Omega Ratio Rank
The Calmar Ratio Rank of CC is 66
Calmar Ratio Rank
The Martin Ratio Rank of CC is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IOSP vs. CC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Innospec Inc. (IOSP) and The Chemours Company (CC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current IOSP Sharpe Ratio is -0.98, which is comparable to the CC Sharpe Ratio of -1.02. The chart below compares the historical Sharpe Ratios of IOSP and CC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

IOSP vs. CC - Dividend Comparison

IOSP's dividend yield for the trailing twelve months is around 0.89%, less than CC's 7.50% yield.


TTM20242023202220212020201920182017201620152014
IOSP
Innospec Inc.
0.89%1.41%1.14%1.24%1.28%1.15%0.99%1.44%1.09%0.98%1.12%1.29%
CC
The Chemours Company
7.50%5.92%3.17%3.27%2.98%4.03%5.53%2.98%0.24%0.54%10.82%0.00%

Drawdowns

IOSP vs. CC - Drawdown Comparison

The maximum IOSP drawdown since its inception was -91.17%, which is greater than CC's maximum drawdown of -86.15%. Use the drawdown chart below to compare losses from any high point for IOSP and CC. For additional features, visit the drawdowns tool.


Loading data...

Volatility

IOSP vs. CC - Volatility Comparison

The current volatility for Innospec Inc. (IOSP) is 6.36%, while The Chemours Company (CC) has a volatility of 18.15%. This indicates that IOSP experiences smaller price fluctuations and is considered to be less risky than CC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

IOSP vs. CC - Financials Comparison

This section allows you to compare key financial metrics between Innospec Inc. and The Chemours Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00B20212022202320242025
440.80M
1.37B
(IOSP) Total Revenue
(CC) Total Revenue
Values in USD except per share items

IOSP vs. CC - Profitability Comparison

The chart below illustrates the profitability comparison between Innospec Inc. and The Chemours Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

15.0%20.0%25.0%30.0%20212022202320242025
28.4%
17.3%
(IOSP) Gross Margin
(CC) Gross Margin
IOSP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Innospec Inc. reported a gross profit of 125.10M and revenue of 440.80M. Therefore, the gross margin over that period was 28.4%.

CC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Chemours Company reported a gross profit of 236.00M and revenue of 1.37B. Therefore, the gross margin over that period was 17.3%.

IOSP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Innospec Inc. reported an operating income of 42.50M and revenue of 440.80M, resulting in an operating margin of 9.6%.

CC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Chemours Company reported an operating income of 78.00M and revenue of 1.37B, resulting in an operating margin of 5.7%.

IOSP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Innospec Inc. reported a net income of 32.80M and revenue of 440.80M, resulting in a net margin of 7.4%.

CC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Chemours Company reported a net income of -4.00M and revenue of 1.37B, resulting in a net margin of -0.3%.